Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Instagram Outage Disrupts Thousands of U.S. Users 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
WILMINGTON, Del., Feb. 08, 2016 -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Talmer Bancorp, Inc. (“Talmer Bancorp” or the “Company”) relating to the sale of the Company to Chemical Financial Corporation (“Chemical Financial”). On January 26, 2016, the two companies announced the signing of a definitive merger agreement pursuant to which Chemical Financial will acquire Talmer Bancorp in a merger in a deal worth $1.1 billion. As a result of the merger, Talmer Bancorp shareholders are only anticipated to receive $1.61 per share in cash and 0.4725 shares of Chemical Financial stock in exchange for each share of Talmer Bancorp. The total consideration Talmer Bancorp shareholders anticipate receiving is roughly $15.64 per share.
Our investigation so far has revealed that the consideration Talmer Bancorp shareholders are expected to receive is inadequate. Analysts at Yahoo! Finance have set a $20.00 per share median price target for Talmer Bancorp, which is approximately 27.8% more than what Talmer Bancorp shareholders are expected to receive.
Our Firm’s investigation so far has also discovered that the process leading up to the announcement of the merger appears to have significant conflicts of interest, thus making the process and consideration unfair. As indicated by the Company, Talmer Bancorp’s President and CEO David T. Provost as well as Gary Torgow, the Company’s chairman, will join the board of directors once the merger is closed.
If you own shares of Talmer Bancorp and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/talmer-bancorp-class-action-investigation or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. This notice may constitute Attorney Advertising.
Contact: Craig J. Springer, Esq. [email protected] Call Toll Free: 1-800-423-6013
